Side-by-side comparison of AI visibility scores, market position, and capabilities
NASDAQ-listed (PRPL) DTC sleep brand with Hyper-Elastic Polymer grid mattresses for pressure relief and temperature regulation; $480M revenue competing with Tempur-Sealy and Sleep Number for premium mattress.
Purple Innovation is a Lehi, Utah-based sleep products company — publicly listed on NASDAQ (NASDAQ: PRPL) — manufacturing and selling mattresses, pillows, cushions, and bedding under the Purple brand, built around the proprietary Hyper-Elastic Polymer grid technology that provides pressure relief, temperature regulation, and responsive support without the heat retention of traditional memory foam. Founded in 2015 by Tony Pearce and Terry Pearce (inventors with foam manufacturing background) and IPO'd via SPAC merger in 2018, Purple generated approximately $480 million in revenue in fiscal year 2024 serving sleep-focused consumers through DTC e-commerce, showrooms, and retail partners including Mattress Firm and Bloomingdale's.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.